Skip to main content
Clinical Trials/IRCT20230508058117N1
IRCT20230508058117N1
Recruiting
Phase 2

Evaluation of the clinical consequences of botulonium toxin a compared to medical treatment in patients with urge incontinence

Tehran University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
urge incontinence.
Sponsor
Tehran University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Accurate diagnosis of patients with urge incontinence based on the diagnosis of a pelvic floor specialist,
  • women over the age of 18,
  • suffering from urge incontinence and in the case of a history of non\-response to antimuscarinic drugs in the past 3 months;
  • Urgent incontinence and having a history of antimuscarinic drug complications (constipation, blurred vision, dry mouth)

Exclusion Criteria

  • Patients with urinary tract infection,
  • interstitial cystitis,
  • having an intermittent or permanent catheter
  • previous pelvic radiotherapy treatment
  • neurogenic urge incontinence
  • a history of sensitivity to Botox;
  • Use of aminoglycoside drugs
  • contraindications for receiving antimuscarinic treatment (tachyrhythmia, angle\-closure glaucoma)

Outcomes

Primary Outcomes

Not specified

Similar Trials